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and in schoolchildren it was atropine (8%). The “probable” and 
“possible” class of causality in babies were 57.2% and 17.1% while 
“certain” class was defined just in 24% of reports. In other groups. 
doctors were more sure in ADRs cause: “certain” class was reported 
in 50%.
Conclusion: This analysis confirms results of previous studies which 
suggest ADRs as significant issues in pediatrics, which gender speci-
fity, clinical presentations, ADR causing agent and seriousness differ 
from the same in adults.
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Introduction: Elderly people of Bangladesh have a strong belief 
that Oxalis perdicaria (Molina) Bertero as pulp or extract can con-
trol loose motion. The mechanism of action on Oxalis perdicaria 
(Molina) Bertero extract is not known but the elderly, especially 
grandmothers, use Oxalis perdicaria (Molina) Bertero extracts for 
their grandchildren who suffer from the loose motion.
Patients (or Materials) and Methods: Evaluate control of motion 
and fluid loss as affected by intake of Oxalis perdicaria (Molina) 
Bertero extract. In the observations, 29 children aged 1 to 2 years, 
having > 5 loose motions/d were randomly advised to take 60 mL 
of Oxalis perdicaria (Molina) Bertero extract (extracted from 50 
leafs with stem). The children were suffering from the persistent 
malnutrition diarrhea. They were also feed Khichdi made with 300 
g of rice, 200 g of vegetables, 2 eggs, 150 g of fish, 150 g of len-
tils, and 30 mL of soybean oil. The total amount of Khichdi was 
divided into 3 meals, and after each meal, 60 mL of Oxalis perdi-
caria (Molina) Bertero extract was given to ingest. They were also 
advised to drink oral saline in between the meals, and if capable, 
to eat fruits, such as Aegle marmelos (L.) Corrêa, Citrus maxima 
(Burm.) Osbeck, Mangifera indica L., Musa acuminata Colla, and 
Psidium guajava L. The observations were conducted at the multi-
center during October 2011 to March 2012. None was admitted to 
hospital. Urinary excretion and stool of each patient were examined 
routinely on the first day and fifth day. After 5 days, they were 
advised to eat normal diets.
Results: On the second day, 6 patients showed controlled motion 
(2–3 motions a day). Eleven cases showed controlled motion on the 
third day, 9 cases on the fourth day, and 3 cases on the fifth day. Signs 
of dehydration were absent in 18 cases on the third day, 9 cases on 
the fourth day, and 2 cases on the fifth day. Motion and dehydration 
both were controlled within the 5 days of Oxalis perdicaria (Molina) 
Bertero therapy.
Conclusion: Treatment of diarrhea with the Oxalis perdicaria 
(Molina) Bertero, a common herb in Bangladesh, is not yet estab-
lished, but the observations on 29 cases in the lessons showed 100% 
cure within 5 days. The indigenously available medicines and tech-
nologies can prove an asset in the tropical and developing countries 
of the world. At the same time, developed countries also can be 
benefited because of safety profile of the plant extracts.
Disclosure of Interest: None declared.
PP230—Pattern Of Parenteral drug 
PrescriPtiOn fOr children under  
the age Of 6 in turkey
B. Donertas1; A. Gelal2*; A. Alkan3; S. Mollahaliloglu4;  
and A. Akici1
1Pharmacology, Marmara University, Istanbul; 2Pharmacology, 
Dokuz Eylul University, Izmir; 3Ministry of Health Turkish 
Medicines and Medical Devices Agency; and 4Health Policies 
Board, Ministry of Health, Ankara, Turkey
Introduction: We aimed to assess parenteral drug (PD) prescription 
patterns for children under the age of 6 at primary health care centers 
(PHCC) in Turkey, using some drug use indicators.
Patients (or Materials) and Methods: PD prescriptions were recruited 
using the databases of the year 2010 recorded in the PHCC of 32 
provinces in Turkey. One hundred PD prescriptions per month from 
each of the 32 provinces were analyzed retrospectively. Of the total 
38,400 PD prescriptions, 2369 (6.2%) were written out for children 
aged 0 to 5.
Results: PD prescriptions were more often written out for boys 
(56.8%). When age distribution was analyzed, it was found that 
PD prescriptions were most often written out for children at age 2 
(24.1%), followed by age 1 (23.3%), age 3 (17.9%), age 5 (14.5%), 
age 4 (13.6%), and age < 1 children (6.6%). Number of drugs per pre-
scription was 2.8 (1.2), number of PD per prescription was 1.1 (0.3). 
PDs constituted 57.8% of the total costs of these prescriptions. PDs 
were more often written out in winter (29.8%), followed by spring 
(27.0%), summer (24.5%), and autumn (18.7%). Most frequently 
prescribed PDs were ceftriaxone (31.6%), followed by benzathine 
benzylpenicillin (14.3%), cefazoline (8.0%) and ampicillin + sulbac-
tam (7.8%). Most frequent diagnoses on the prescriptions were acute 
tonsillitis (24.5%), followed by acute bronchitis (20.3%), acute phar-
yngitis (6.1%), and acute upper respiratory tract infection (3.8%).
Conclusion: In small children, PDs were more frequently prescribed 
for respiratory tract infection, in winter and third-generation cepha-
losporins were the most frequently prescribed PDs. The overuse of 
third-generation cephalosporins as revealed in our study represent 
a major concern for the public health because it could be associated 
with increased antibiotic resistance.
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Introduction: Literature regarding acute human toxicity of thio-
purines and mycophenolate (MMF) is limited to a handful of case 
reports. There are no published reports of sirolimus (SIR) overdose. 
The aim of this study was to investigate the circumstances and out-
comes of overdoses (ODs) with thiopurines, MMF, and SIR using 
data reported to a single national poison center.
Patients (or Materials) and Methods: A retrospective review was 
performed of all acute ODs involving thiopurines (azathioprine 
and 6-mercaptopurine), MMF, and SIR in adults and children (< 16 
years) reported to the Swiss Toxicological Information Centre (STIC) 
between 1995 and 2012.
